Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Vaxil Bio Ltd V.VXL

Alternate Symbol(s):  VXLLF

Vaxil Bio Ltd. is a Canada-based biotechnology company. The Company is focused on a drug discovery and development platform based on Signal Peptides (SPs) which the Company deploys to fight infectious diseases and cancer. The Company’s most advanced product, ImMucin, a MUC1 SP-derived vaccine, completed a Phase I/II clinical trial in multiple myeloma. The Company also has a SP-based COVID-19 vaccine candidate and a SP-based tuberculosis vaccine / treatment candidate. In addition, The Company has mAb candidates for the treatment of oncology and infectious diseases to be used alone, and in combination with other treatments. It has also initiated a pre-clinical program for a drug delivery polymer that targets high affinity E-selectin (P-Esbp), which the Company licensed for development and commercialization from BGN Technologies. It exploits the properties of SP domains on crucial proteins to develop targeted therapies against cancer targets and infectious disease pathogens.


TSXV:VXL - Post by User

Bullboard Posts
Post by Kingofstockston Mar 13, 2020 6:04pm
93 Views
Post# 30806373

Everything

Everything That goes up must come down, that's how the works works. Now it's ticker:lbl turn as you may have noticed Nasdaq reports are pretty good at calling stocks before they run just as they did with vxl. Now it's lbl turn to fly get in Monday..Friday, 13 March 2020 Lattice Biologics Is The Next Vaxil Bio On February 27,we issued an alerton Vaxil Bio (VXL.V) (VXLLF) as the next big Coronavirus play hidden on the TSX Venture. Since then, VXL has risen to $0.26 from $0.08 and has hit as high as $0.34. We are issuing another alert on a Coronavirus play on the TSX Venture that is very similar in nature to VXL.Lattice Biologics Ltd. (LBL.V) (LBLTF)c
Bullboard Posts